MSF urges Indian Patent Office to reject Gilead Sovaldi patent

02-03-2016

MSF urges Indian Patent Office to reject Gilead Sovaldi patent

blackboard1965 / Shutterstock.com

Médecins Sans Frontières (MSF) has urged the Indian Patent Office (IPO) to reject a Gilead Sciences patent application covering Sovaldi (sofosbuvir).


Médecins Sans Frontières; MSF; Indian Patent Office; Gilead Sciences; hepatitis C; I-MAK; Sovaldi; sofosbuvir

LSIPR